Mat Carré SRL
Mat Carré reported total assets of 29,229 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Mat Carré shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +3 % Total assets -48 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mat Carré's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Mat Carré's financial analysis
- Solvency97.6%sector median: 46.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mat Carré
Mat Carré's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0562.789.941
- VAT number
- BE0562789941
- Peppol
- Registered · 0208:0562789941 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Sep 2014
- Registered office
- 4050 Chaudfontaine
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Manufacture of medical and dental instruments and supplies (NACE 32500)
Mat Carré (SRL) has been based in Chaudfontaine since 2014, active in: manufacture of medical and dental instruments and supplies. For 2025, it reports a net loss of 658 € and equity of 28,528 €; its revenue is not published. Its solvency stands at 97.6%, above the median of its sector (46.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Mat Carré
Companies in the same business, of comparable size and area, outside its group.
- Code16 Manufacture of medical and dental instruments and supplies Ingelmunster · balance sheet 29,377 €
- Laboratoire Dentaire Hernandez Manufacture of medical and dental instruments and supplies Tournai · balance sheet 31,917 €
- Audioprothese Manufacture of medical and dental instruments and supplies Berchem-Sainte-Agathe · balance sheet 124,571 €
- FEL Technics Manufacture of medical and dental instruments and supplies Lierde · balance sheet 86,661 €
- Seco Labo Manufacture of medical and dental instruments and supplies Landen · balance sheet 42,109 €
- Magicramp Europe Manufacture of medical and dental instruments and supplies Thimister-Clermont · balance sheet 43,313 €
- Buyle Manufacture of medical and dental instruments and supplies Blankenberge · balance sheet 40,598 €
- Orthotec Evolution Manufacture of medical and dental instruments and supplies Seraing · balance sheet 17,590 €
Frequently asked questions about Mat Carré
What is the revenue of Mat Carré?
Mat Carré files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mat Carré?
In Belgium, the VAT number is the company number prefixed with BE: BE0562789941 for Mat Carré, if the company is VAT-registered. Its company number (CBE) is 0562.789.941.
Where is the registered office of Mat Carré?
According to the CBE register, the registered office of Mat Carré is in 4050 Chaudfontaine.
What is the equity of Mat Carré?
At the close of the 2025 financial year, the equity of Mat Carré amounts to 28,528 €, a solvency of 97.6% of total assets.
Who manages Mat Carré?
The register lists 1 active mandates at Mat Carré. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mat Carré
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →